Clinical trial
Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Poorly Healed Wounds of Postoperative Incision
NCT04538885 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Poorly Healed Wounds of Postoperative Incision
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- September 10, 2020
- Completion date
- May 30, 2021
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
mscs-pfs in treating poorly healed wounds of postoperative incision